Quanterix (QTRX) Cash from Investing Activities (2017 - 2026)
Quanterix (QTRX) reported Cash from Investing Activities of $25.3 million for Q1 2026, down 22.89% on a YoY basis from $32.8 million in Q1 2025, and up 199.36% quarter-over-quarter from $8.4 million in Q4 2025.
Quanterix (QTRX) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Quanterix has reported Cash from Investing Activities for 10 years, with the latest figure at $25.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 22.89% year-over-year to $25.3 million; the trailing twelve-month figure through Mar 2026 stood at $42.7 million (down 28.41% YoY), and the FY2025 full-year result was $50.2 million, up 161.06% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $25.3 million, up from $8.4 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $61.9 million in Q2 2025, with the low at -$126.1 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$9.8 million across 5 years, with a median of -$815000.0 in 2022.
- The largest YoY upside for Cash from Investing Activities was 960.05% in 2024 against a maximum downside of 80190.44% in 2024.
- Quanterix's Cash from Investing Activities stood at -$1.6 million in 2022, then sank by 1240.19% to -$21.4 million in 2023, then jumped by 251.5% to $32.4 million in 2024, then plunged by 73.94% to $8.4 million in 2025, then surged by 199.36% to $25.3 million in 2026.
- The last three Cash from Investing Activities figures came in at $25.3 million (Q1 2026), $8.4 million (Q4 2025), and -$52.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Quanterix | 146.10 Mn | 46.84 Mn | 15.57 Mn | 25.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.26 Mn |
| Mar 31, 2026 | 25.26 Mn |
| Dec 31, 2025 | 8.44 Mn |
| Dec 31, 2025 | 8.44 Mn |
| Sep 30, 2025 | -52.85 Mn |
| Sep 30, 2025 | -52.85 Mn |
| Jun 30, 2025 | 61.88 Mn |
| Jun 30, 2025 | 61.88 Mn |
| Mar 31, 2025 | 32.76 Mn |
| Mar 31, 2025 | 32.76 Mn |
| Dec 31, 2024 | 32.38 Mn |
| Dec 31, 2024 | 32.38 Mn |
| Sep 30, 2024 | -12.43 Mn |
| Sep 30, 2024 | -12.43 Mn |
| Jun 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 6.98 Mn |
| Mar 31, 2024 | -109.20 Mn |
| Mar 31, 2024 | -109.20 Mn |
| Dec 31, 2023 | -21.38 Mn |
| Dec 31, 2023 | -21.38 Mn |